
‘New hope': ash trees rapidly evolving resistance to dieback, study reveals
New generations of wild ash trees are rapidly evolving resistance to the fungus devastating their numbers, scientists have discovered.
The discovery gives hope, the researchers said, and shows that allowing the natural regeneration of woodlands is vital to enabling this evolution to take place. However, it remains too early to say if the development of resistance in the ash trees can outpace the destruction being caused by the ash dieback fungus.
The genetic analysis is also a scientific breakthrough. It is the first convincing proof of a prediction made by Charles Darwin that significant changes in organisms can result from natural selection driving very many small changes, not just from one or two obvious ones.
Ash dieback is caused by the invasive Hymenoscyphus fraxineus fungus, which was first identified in the UK in 2012 and is also killing trees across Europe. It has killed millions in the UK and is expected to wipe out up to 85% of the older, non-resistant ash trees, incurring costs of £15bn.
Previous studies found apparent resistance in some ash saplings but the new study gives in-depth genetic information that could help breeding programmes to support the natural recovery of ash trees.
'Our new findings give us new hope,' said Prof Richard Buggs, at the Royal Botanic Gardens Kew and Queen Mary University of London (QMUL): 'Elm trees have struggled to evolve to Dutch elm disease, but ash produce an abundance of seedlings upon which natural selection can act when they are still young. Through the death of millions of ash trees, a more resistant population of ash is appearing.'
Prof Richard Nichols, also at QMUL, said: 'We have to be cautious. We can't say the ash is saved, but we are in a position to say it's looking promising. We are watching evolution happen and what's remarkable is that it's happening so quickly, in a single generation.' One ash tree can produce 10,000 genetically distinct seeds in one season, leading to scores of saplings.
The study, published in the journal Science, compared the DNA of trees that were already growing before ash dieback's arrival with younger trees that were established after.
The new trees have to grow up through the leaf mould where the fungus replicates and the researchers found that about 30% of these were killed by ash dieback, providing a strong driving force for evolution. 'Only the fittest survive – those that made it through that intense early episode of selection,' said Nichols.
Previous genetic work had identified thousands of locations in ash DNA that appeared to either protect the trees from dieback, or make them more vulnerable. The scientists recorded subtle changes at these locations, showing the younger generation possessed greater resistance than their predecessors.
This showed that the DNA changes predicted whether saplings were more likely to flourish or die and therefore demonstrated that Darwinian evolution by natural selection was taking place.
Sign up to Down to Earth
The planet's most important stories. Get all the week's environment news - the good, the bad and the essential
after newsletter promotion
Ash dieback kills trees slowly and Nichols said the research showed the best strategy was to keep as many trees alive as possible to allow their offspring to evolve. Felling and destroying infected trees would mean important genetic variability was lost.
Rebecca Gosling, of the Woodland Trust, which owns Marden Park woods in Surrey, where the study took place, said: 'The findings highlight how vital it is to support natural regeneration in woodlands, furthering our understanding of how to best manage our ash woodlands.'
'However, natural selection alone may not be enough to produce fully resistant trees,' said Dr Carey Metheringham, at QMUL. 'The existing genetic variation in the ash population may be too low, and as the trees become scarcer, the rate of selection could slow.'
Therefore, human interventions may also be required to support ash tree recovery, the researchers said. This could include selective breeding for resistant varieties, cross-breeding with Asian ash trees, which evolved with the fungus and are therefore highly resistant, or even gene editing.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Guardian
28 minutes ago
- The Guardian
Tom Holland, Jacob Elordi and Harris Dickinson at top of James Bond wishlist
Tom Holland, Harris Dickinson and Jacob Elordi are rumoured to be at the top of Amazon's James Bond wishlist, according to a new report. Variety has learned from insiders that the new iteration of 007 would be under 30 and the three actors could be fighting it out for the role. No meetings have taken place and Amazon has yet to confirm anything. The report emerges days after the Dune and Arrival director Denis Villeneuve was announced as the first director of Bond's new era under the Amazon-MGM banner. The French-Canadian film-maker, now working on the third Dune movie, reportedly beat out Conclave's Edward Berger, Westworld's Jonathan Nolan, Paddington's Paul King and Shaun of the Dead's Edgar Wright for the role. 'I intend to honour the tradition and open the path for many new missions to come,' Villeneuve said in a statement. 'This is a massive responsibility, but also, incredibly exciting for me and a huge honour.' Early rumours had suggested the Gravity director Alfonso Cuarón would step up, having worked with Bond's new producer David Heyman before, but he removed himself from the race. Cuarón is set to work on the darkly funny drama Jane with Charlize Theron instead. Holland, best known for playing Spider-Man, has also starred in the video game hit Uncharted and Apple series The Crowded Room. He'll next be seen in Christopher Nolan's The Odyssey before returning for the fourth Spider-Man movie. The 29-year-old actor once tried to pitch a 007 spin-off to Sony. 'I had a meeting after or during Spider-Man 2 with Sony to pitch this idea of a young Bond film that I'd come up with,' he said in 2022. 'It was the origin story of James Bond. It didn't really make sense. It didn't work. It was the dream of a young kid, and I don't think the Bond estate were particularly interested.' Dickinson, known for Triangle of Sadness and Babygirl, recently received rave reviews for his directorial debut Urchin at the Cannes film festival. 'I mean, listen, man, you'd be a fool to not entertain that role,' he said when asked about playing Bond in 2023. 'I'm loving seeing the development of James Bond and seeing how it changes over the years. I think Daniel Craig was such a good Bond that I'd almost be quite frightened to try … Who knows what they're doing with Bond? I'm intrigued.' Elordi is the only Australian of the bunch, but could follow in the footsteps of George Lazenby who played Bond in On Her Majesty's Secret Service. The actor, best known for his role in TV drama Euphoria and Sofia Coppola's Priscilla, will soon be seen in Emerald Fennell's unconventional adaptation of Wuthering Heights with Margot Robbie. In 2023, Elordi called rumours that he was being linked to the role 'beautiful' and added: 'I just like that people maybe want to put me in their movies. That makes me really glad.' The release date for the next film is yet to be announced, but Variety is claiming that anything sooner than 2028 would be impossible. The 26th Bond film will follow Daniel Craig's final outing No Time to Die which made over $774m at the global box office. Earlier this year, in a reported $1bn deal, Amazon MGM bought the rights to gain 'creative control' of the franchise. In March, producers Amy Pascal and David Heyman were hired to take charge of the new film.


The Guardian
an hour ago
- The Guardian
Ethical questions surround the NHS sampling babies' DNA
Re your report (All babies in England to get DNA test to assess risk of diseases within 10 years, 20 June), the NHS plans to test the DNA of all babies to 'assess disease risk', in association with AI, having already sampled 100,000 newborns. The Department of Health and Social Care said that genomics and AI would be used to 'revolutionise prevention' and provide faster diagnoses and an 'early warning signal for disease'. In line with previous predictions, when individuals who submitted to a PCR test (which amplifies genetic material) during Covid-19 had their DNA sold for profit without their consent, infants now face their private, personal, biological data being captured, stored and used by who-knows-what corporations on behalf of the NHS. Not everyone wants to know what potential diseases they might suffer from in the future, especially if there is no known treatment. And for what purposes might it be used, other than 'prediction of disease risk'? Testing of new drugs? Testing of vaccines? Clearly an infant cannot give consent to its DNA being used for these purposes and research on children is unethical unless they stand to benefit. Will parents have the opportunity to give informed consent and can it even be informed if they are unaware of the many potential uses of the material? A global genomics market of $32.65bn in 2023 suggests that this is big business. Genomics England already makes available patients' genomic data to businesses. The association with AI additionally raises the spectre of surveillance in the form of digital IDs, incorporating not only biometric data, such as fingerprints, retinal scans and facial recognition, but potentially even the human genome itself. The NHS data of 57 million patients has already been used to train AI outside of the intended purpose. Will doctors recognise these risks and take steps to inform patients? Or will technology roll on regardless?Janet MenageRetired GP, Llanybydder, Ceredigion Have an opinion on anything you've read in the Guardian today? Please email us your letter and it will be considered for publication in our letters section.


The Independent
2 hours ago
- The Independent
New ancient discovery unearthed at popular dog walking spot
Volunteer archaeologists uncovered a Bronze Age burial site at Trelai Park in Cardiff, Wales. Human remains, believed to be cremations from the Bronze Age, were found in three pits during an archaeological dig. The cremations were discovered next to a 1500 BC roundhouse previously found at the site. Experts suggest the proximity of the remains indicates the site held significant ceremonial importance or was a burial ground for cherished family members. The discovery highlights the rich history of Trelai Park, suggesting it has been an important location for thousands of years.